BRIEF-Amylyx Pharmaceuticals Q4 EPS USD -0.3 Vs. IBES Estimate USD -0.36

Amylyx Pharmaceuticals, Inc. +2.73% Pre

Amylyx Pharmaceuticals, Inc.

AMLX

16.92

16.92

+2.73%

0.00% Pre

Mar 03 (Reuters) - Amylyx Pharmaceuticals Q4 operating income USD -36.605 million vs. IBES estimate USD -40.4 million.

  • Q4 operating expenses USD 36.605 million
  • Q4 net income USD -32.999 million vs. IBES estimate USD -37.1 million
  • Q4 pretax profit USD -32.953 million vs. IBES estimate USD -39 million
  • Q4 cash & investments USD 317 million